{{Rsnum
|rsid=2856836
|Gene=IL1A
|Chromosome=2
|position=112774506
|Orientation=plus
|GMAF=0.2029
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=IL1A
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 7.1 | 36.3 | 56.6
| HCB | 0.0 | 13.1 | 86.9
| JPT | 1.8 | 18.6 | 79.6
| YRI | 1.4 | 28.6 | 70.1
| ASW | 0.0 | 28.1 | 71.9
| CHB | 0.0 | 13.1 | 86.9
| CHD | 0.0 | 13.8 | 86.2
| GIH | 8.9 | 42.6 | 48.5
| LWK | 1.8 | 31.8 | 66.4
| MEX | 5.2 | 37.9 | 56.9
| MKK | 7.1 | 32.7 | 60.3
| TSI | 8.8 | 36.3 | 54.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=20127018
|Title=Multiplex genotyping of 1107 SNPs from 232 candidate genes identified an association between IL1A polymorphism and breast cancer risk
}}

{{PMID Auto
|PMID=18063673
|Title=Prospective meta-analysis of interleukin 1 gene complex polymorphisms confirms associations with ankylosing spondylitis.
}}

{{PMID Auto
|PMID=22312160
|Title=Association between the IL-1 family gene cluster and spondyloarthritis.
}}

{{PMID Auto
|PMID=21962386
|Title=The associations between interleukin-1 polymorphisms and susceptibility to ankylosing spondylitis: a meta-analysis.
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}